XML 35 R24.htm IDEA: XBRL DOCUMENT v3.23.2
SHAREHOLDERS' EQUITY (Detail Textuals)
$ / shares in Units, $ in Thousands
 1 Months Ended 6 Months Ended 30 Months Ended
Jan. 31, 2023
USD ($)
Apr. 14, 2020
USD ($)
shares
Oct. 10, 2018
USD ($)
$ / shares
shares
Jun. 14, 2018
USD ($)
$ / shares
shares
Nov. 30, 2021
USD ($)
$ / shares
shares
Mar. 16, 2020
$ / shares
shares
Jun. 30, 2023
USD ($)
$ / shares
shares
Jun. 30, 2022
USD ($)
$ / shares
shares
Jun. 30, 2023
USD ($)
Jun. 30, 2023
₪ / shares
Jun. 30, 2023
USD ($)
shares
Dec. 31, 2022
₪ / shares
shares
Ordinary shares, par value | ₪ / shares                   ₪ 0.01   ₪ 0.01
Value of shares issued             $ 1,154          
Ordinary shares, shares authorized | shares                     200,000,000 200,000,000
Options granted | shares             19,500          
Stock options granted, exercise price, minimum | $ / shares             $ 0.67          
Stock options granted, exercise price, maximum | $ / shares             $ 1.06          
Vesting period             4 years          
Weighted average fair value of options granted during period | $ / shares             $ 0.53 $ 1.94        
Share based compensation stock options             $ 1,782 $ 2,092        
Unrecognized estimated compensation cost                     $ 6,267  
Period over which compensation expense will be recognized             2 years 29 days          
Total weighted average number of shares related to outstanding options and warrants excluded from the calculations of diluted net loss per share | shares             7,460,568 8,504,958        
Employee Stock Purchase Plan [Member]                        
Number of shares purchased for ESPP | shares             275,854          
Ordinary shares available for issuance | shares | shares                     324,146  
Share based compensation ESPP             $ 0 $ 97        
Warrant [Member]                        
Warrants purchase to ordinary shares | shares                     3,955,696  
Proceeds from warrant exercised                 $ 18,750      
Warrants purchase to ordinary shares remain outstanding | shares                     297,469  
Agreement [Member] | Registered direct offering [Member]                        
Value of shares issued       $ 19,767                
Issuance expenses       $ 1,233                
Ordinary shares, shares authorized | shares       5,316,457                
Warrants purchase to ordinary shares | shares       4,253,165                
Offering price per share | $ / shares       $ 3.95                
Exercise price of warrants | $ / shares       $ 4.74                
Expiration period of warrants       5 years                
Master Clinical Agreement [Member]                        
Ordinary shares issued | shares     2,424,243   2,332,815              
Offering price per share | $ / shares     $ 4.95   $ 8.57333              
Equity investment     $ 12,000   $ 20,000              
Percentage of closing price     33.00%   33.00%              
Collaborative Arrangements [Member]                        
Issuance expenses             91          
Relative fair value of deferred participation                     $ 4,121  
Proceeds from equity investments             7,788          
Collaborative Arrangements Two [Member]                        
Issuance expenses             42          
Relative fair value of deferred participation                     $ 5,000  
Proceeds from equity investments             $ 14,958          
SVB Leerink LLC and Stifel, Nicolaus & Company [Member]                        
Ordinary shares issued | shares   8,816,339       8,333,334            
Issuance expenses   $ 5,200                    
Offering price per share | $ / shares           $ 9            
Proceeds from ordinary shares in offering   $ 74,147                    
SVB Leerink LLC and Stifel, Nicolaus & Company [Member] | Underwriters [Member]                        
Ordinary shares issued | shares   483,005                    
Offering price per share | $ / shares           $ 8.46            
Sales Agreement With Leerink Partner LLC [Member]                        
Proceeds from issuance of common stock $ 50,000                      
Ordinary shares issued | shares             1,609,123          
Issuance expenses             $ 458          
Proceeds from ordinary shares in offering             $ 1,154